Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

Norman E. Lepor, Stacey B. Gross, William L. Daley, Bruce A. Samuels, Michael J. Rizzo, Sean P. Luko, Ann Hickey, Neil A. Buchbinder, Tasneem Zehra Naqvi

Research output: Contribution to journalArticle

28 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)107-110
Number of pages4
JournalAmerican Journal of Cardiology
Volume86
Issue number1
DOIs
StatePublished - Jul 1 2000
Externally publishedYes

Fingerprint

Drug Dose Response Relationship
Phentermine
Doppler Color Echocardiography
Myocardial Contraction
Fenfluramine
Right Ventricular Function
Appetite Depressants
Heart Valve Diseases
Observer Variation
Aortic Valve Insufficiency
Blood Flow Velocity
Serotonin Uptake Inhibitors
Mitral Valve Insufficiency
Electrocardiography
Retrospective Studies
Observation
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease. / Lepor, Norman E.; Gross, Stacey B.; Daley, William L.; Samuels, Bruce A.; Rizzo, Michael J.; Luko, Sean P.; Hickey, Ann; Buchbinder, Neil A.; Naqvi, Tasneem Zehra.

In: American Journal of Cardiology, Vol. 86, No. 1, 01.07.2000, p. 107-110.

Research output: Contribution to journalArticle

Lepor, NE, Gross, SB, Daley, WL, Samuels, BA, Rizzo, MJ, Luko, SP, Hickey, A, Buchbinder, NA & Naqvi, TZ 2000, 'Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease', American Journal of Cardiology, vol. 86, no. 1, pp. 107-110. https://doi.org/10.1016/S0002-9149(00)00840-7
Lepor, Norman E. ; Gross, Stacey B. ; Daley, William L. ; Samuels, Bruce A. ; Rizzo, Michael J. ; Luko, Sean P. ; Hickey, Ann ; Buchbinder, Neil A. ; Naqvi, Tasneem Zehra. / Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease. In: American Journal of Cardiology. 2000 ; Vol. 86, No. 1. pp. 107-110.
@article{35e7c8393064493aaed6a5d31d55b1bd,
title = "Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease",
author = "Lepor, {Norman E.} and Gross, {Stacey B.} and Daley, {William L.} and Samuels, {Bruce A.} and Rizzo, {Michael J.} and Luko, {Sean P.} and Ann Hickey and Buchbinder, {Neil A.} and Naqvi, {Tasneem Zehra}",
year = "2000",
month = "7",
day = "1",
doi = "10.1016/S0002-9149(00)00840-7",
language = "English (US)",
volume = "86",
pages = "107--110",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

AU - Lepor, Norman E.

AU - Gross, Stacey B.

AU - Daley, William L.

AU - Samuels, Bruce A.

AU - Rizzo, Michael J.

AU - Luko, Sean P.

AU - Hickey, Ann

AU - Buchbinder, Neil A.

AU - Naqvi, Tasneem Zehra

PY - 2000/7/1

Y1 - 2000/7/1

UR - http://www.scopus.com/inward/record.url?scp=0034237285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034237285&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(00)00840-7

DO - 10.1016/S0002-9149(00)00840-7

M3 - Article

VL - 86

SP - 107

EP - 110

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -